Qingsong Health (02661): Stabilization Period Concludes with No Price-Stabilizing Actions and Over-Allotment Option Lapses

Stock News
01/18

The stabilization period in relation to the global offering concluded on January 17, 2026 (Saturday), which was the 30th day after the deadline for submitting applications under the Hong Kong public offering.

Since there was no over-allocation in the international offering, the sponsor and overall coordinator (for itself and on behalf of the international underwriters) did not exercise the over-allotment option, and the stabilizing manager or any person acting on its behalf did not undertake any stabilizing actions during the stabilization period.

The over-allotment option lapsed on January 17, 2026 (Saturday), the 30th day following the deadline for submitting Hong Kong public offering applications.

Consequently, no shares have been or will be issued pursuant to the over-allotment option.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10